[Intraocular inflammation with occlusive retinal vasculitis following intravitreal injection of brolucizumab]

Ophthalmologe. 2022 Mar;119(3):296-299. doi: 10.1007/s00347-021-01341-4. Epub 2021 Feb 24.
[Article in German]
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Inflammation / drug therapy
  • Intravitreal Injections
  • Retinal Vasculitis* / chemically induced
  • Retinal Vasculitis* / diagnosis
  • Retinal Vasculitis* / drug therapy
  • Uveitis*

Substances

  • Antibodies, Monoclonal, Humanized
  • brolucizumab